NEW YORK, Aug. 13 /PRNewswire/ -- Manhattan Diagnostic Radiology announced today that it will be the first imaging facility in Manhattan to offer Positron Emission Mammography (PEM) in the fight against breast cancer. This installation will provide Manhattan Diagnostic Radiology an increased ability to image and diagnose early-stage breast cancers, positively impacting cancer management. The leading-edge technology provides unprecedented metabolic resolution down to 1.5 millimeters.
“We recently received prestigious designation as a Breast Imaging Center of Excellence from the American College of Radiology acknowledging our commitment to providing the highest level of breast care to our patients,” said Craig H. Sherman, M.D., Senior Partner and Director of PET/CT imaging at Manhattan Diagnostic Radiology. “We have always sought out the very best in diagnostic imaging technology, and PEM will be the latest in a long list of firsts for our center. We expect that PEM will prove indispensable to effective breast cancer management for both our referring physicians and our patient population.”
“Manhattan Diagnostic Radiology is widely respected for its superior diagnostic skills and comprehensive services. We are excited to play a part in what they do best,” said Paul J. Mirabella, Chairman and CEO of Naviscan.
The PEM Flex scanner from Naviscan uses PET technology to produce high-resolution tomographic images of 1.5 millimeters resolution, allowing physicians to visualize breast tumors about the size of a grain of rice. The scanner is the size of a mammography unit and consists of two high-resolution detector heads which are placed in close proximity to the breast. Compared to the higher-force compression necessary for mammography, the PEM Flex scanner uses gentle breast immobilization.
About Naviscan, Inc.
Naviscan(R), founded in 1995, develops and markets compact, high-resolution PET scanners intended to provide organ-specific molecular imaging, guide radiological and surgical procedures and advance new clinical therapies. The PEM Flex(R) Solo II is currently installed and available in breast centers and imaging centers throughout the U.S. PEM Flex is also utilized in clinical research studies, funded in part by the National Institutes of Health. The Company is headquartered in San Diego, California and is the first company to obtain FDA clearance of a high-resolution PET scanner designed to image small body parts. For more information, visit http://www.naviscan.com
About Manhattan Diagnostic Radiology (MDR)
As one of the premiere diagnostic radiology centers in New York City and the surrounding Tri-State area, the physicians of Manhattan Diagnostic Radiology have set new standards of excellence in diagnostic expertise, advanced imaging technology, patient care and women’s health. Based in Manhattan, NY, MDR was one of the first centers in New York City to utilize PET technology in a comfortable and friendly outpatient environment. Further, MDR is one of the very few full-service radiology practices to specialize in high field MRI, PET/CT, 64-Slice CT and Coronary Artery CT, Nuclear Medicine, Multimodality Breast Imaging, Ultrasound, General Diagnostic Radiology, and Outpatient Fine Needle Aspiration and Core Biopsy. MDR remains at the forefront of radiologic technology, as one of first centers to offer Breast MRI in an outpatient setting, and one of the only practices in the entire Tri-State area to routinely conduct complex MR studies including secretin MRCP and pelvic floor defecography. With the acquisition of PEM technology, MDR further continues its commitment to excellence and as a pioneer in the area of women’s health. For more information, visit http://www.mdrny.com.
CONTACT: Craig H. Sherman, M.D. of Manhattan Diagnostic Radiology,
+1-212-838-4243; or Guillaume Bailliard, VP, Marketing of Naviscan, Inc.,
+1-858-332-0941
Web site: http://www.naviscan.com/
http://www.mdrny.com/
